… RNA medicines for the treatment of severe genetic rarediseases,today announced that the U.S. Food and Drug … QR-421a, our second therapy for an inherited retinal disease, into the clinic and continuing the development of …
Presentation at the 18th International Symposium on Retinal Degeneration (RD2018) at 8:30 am GMT on Sept. 5th Investor conference call to be held at 8:15 am ET on Sept. 5th